Hexa His Tag Peptide (A6006): Precision in Protein Purification

Executive Summary: The Hexa His tag peptide (sequence: HHHHHH) is a synthetic tool enabling specific, competitive elution of 6X His-tagged proteins from anti-His antibody matrices, minimizing antibody contamination in eluates (product_spec). Its defined molecular weight (840.85 Da) and stability profile facilitate reliable protocol integration, with high solubility across DMSO (≥84.1 mg/mL), ethanol (≥123.4 mg/mL, ultrasonic), and water (≥67.5 mg/mL) (product_spec). By mimicking the metal-binding motif of recombinant proteins, it supports robust immunoprecipitation and protein interaction analysis workflows (Mooren et al. 2026). APExBIO supplies this reagent as SKU A6006, validated for compatibility with anti-His beads and conventional immunoprecipitation protocols (product_spec).

Biological Rationale

Polyhistidine tags (His tags) are widely engineered into recombinant proteins to facilitate purification and detection. The 6X His tag peptide specifically mimics the metal-binding sequence found at protein termini, promoting selective interaction with metal-affinity matrices or anti-His antibodies (Mooren et al. 2026). This mechanism underpins many protein purification using anti-His antibody protocols. The approach leverages the strong affinity of imidazole side chains for transition metals or for the paratope of anti-His antibodies, enabling both capture and competitive displacement of His-tagged proteins (Decoding the Hexa His Tag Peptide). This article extends mechanistic insights by explicitly linking peptide solubility and design to outcomes in competitive elution and contamination avoidance, updating previous overviews focused primarily on mechanistic theory.

Mechanism of Action of Hexa His tag peptide

The Hexa His tag peptide functions as a competitive ligand. Its six consecutive histidine residues (HHHHHH) bind with high affinity to the antigen-binding site of anti-6X His antibodies or to immobilized metal ions, depending on the purification platform (product_spec). This competitive binding displaces His-tagged target proteins from the antibody or resin, enabling their elution in a controlled manner. Unlike imidazole-based elution, the peptide avoids co-elution of antibody heavy and light chains, a frequent contaminant in traditional immunoprecipitation (BudipineKits.com). Its molecular definition ensures batch-to-batch consistency and predictable performance.

Evidence & Benchmarks

• The Hexa His tag peptide (A6006) has a measured molecular weight of 840.85 Da and chemical formula C36H44N18O7 (product_spec).
• Solubility values: ≥84.1 mg/mL in DMSO, ≥123.4 mg/mL in ethanol (with ultrasonic assistance), and ≥67.5 mg/mL in water (product_spec).
• Competitive elution with Hexa His tag peptide eliminates antibody chain contamination in immunoprecipitation eluates (BudipineKits.com).
• Peptide-based elution preserves the functional integrity of His-tagged proteins for downstream protein interaction analysis (T7-Tag.com).
• Batch-to-batch reproducibility is supported by precise manufacturing and molecular definition, as documented by APExBIO (product_spec).
• In a study of actin-binding protein workflows, the 6X His tag peptide enabled quantitative recovery of tagged CARMIL constructs without interference with actin capping activity (Mooren et al. 2026).

Applications, Limits & Misconceptions

The Hexa His tag peptide is applied in:

• Protein purification workflows: Enables elution of His-tagged recombinant proteins from anti-His antibody matrices (Hexa-His.com). This article clarifies best practices for maximizing elution specificity compared to prior coverage of protocol scenarios.
• Immunoprecipitation of His-tagged proteins: Reduces contamination from antibody chains, supporting cleaner mass spectrometry or western blot analysis (T7-Tag.com).
• Protein interaction analysis: Provides uncontaminated eluates for downstream binding or functional assays. This update links quantitative recovery with functional validation, extending prior workflow summaries.

Common Pitfalls or Misconceptions

• The Hexa His tag peptide is not suitable for eluting proteins bound via metal affinity (IMAC) without anti-His antibody involvement; imidazole or pH shift is required in such workflows (workflow_recommendation).
• Over-concentration of peptide may inhibit downstream activity assays; titrate for minimal effective displacement (workflow_recommendation).
• Peptide solutions are prone to hydrolysis or microbial contamination if stored in aqueous solution at room temperature; use freshly prepared solutions and store desiccated at -20°C (product_spec).
• Not all anti-His antibodies recognize the same epitope; confirm compatibility with the antibody used (workflow_recommendation).
• Peptide is not suitable as a blocking reagent for all anti-His ELISA formats due to potential cross-reactivity (workflow_recommendation).

Workflow Integration & Parameters

Protocol Parameters

• Protein immunoprecipitation | 0.5–2 mM peptide | anti-His antibody beads | Competitive elution of His-tagged proteins with minimal antibody contamination | workflow_recommendation
• Stock solution preparation | ≥84.1 mg/mL in DMSO | Peptide solubilization | DMSO offers high solubility and stability for aliquoting | product_spec
• Working solution storage | Use fresh or store ≤24 h at 4°C | All workflows | Prevents degradation and preserves peptide integrity | product_spec
• Purification buffer | pH 7.4–8.0, physiological salt | Immunoprecipitation | Maintains antibody binding and peptide solubility | workflow_recommendation
• Anti-His antibody selection | Confirm epitope compatibility | All applications | Ensures efficient competition and elution | workflow_recommendation

Conclusion & Outlook

The Hexa His tag peptide (A6006, APExBIO) offers a robust, contamination-free alternative to imidazole for competitive elution in protein purification using anti-His antibody systems (product_spec). Its molecular precision and validated solubility support reproducible workflows for immunoprecipitation of His-tagged proteins and downstream protein interaction analysis (Mooren et al. 2026). By linking mechanistic design with protocol benchmarks, this article updates and clarifies best practices for next-generation recombinant protein workflows. For further practical guidance and scenario-driven troubleshooting, see the protocol-driven discussion at EpitopePeptide.com, which addresses real laboratory challenges not covered in this overview.